Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Japan Tissue Engineering Co., Ltd.
  6. Summary
    7774   JP3389610001

JAPAN TISSUE ENGINEERING CO., LTD.

(7774)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
680 691 677 672 667 Last
4200 15900 17600 9400 12400 Volume
+0.59% +1.62% -2.03% -0.74% -0.74% Change
Estimated financial data (e)
Sales 2022 3 602 M 31,6 M 31,6 M
Net income 2022 234 M 2,05 M 2,05 M
Net Debt 2022 - - -
P/E ratio 2022 116x
Yield 2022 1,20%
Sales 2023 4 649 M 40,8 M 40,8 M
Net income 2023 739 M 6,47 M 6,47 M
Net Debt 2023 - - -
P/E ratio 2023 36,6x
Yield 2023 1,50%
Capitalization 26 600 M 233 M 233 M
Capi. / Sales 2022 7,38x
Capi. / Sales 2023 5,72x
Nbr of Employees 200
Free-Float 27,6%
More Financials
Company
Japan Tissue Engineering Co., Ltd. is a Japan-based company principally engaged in the development, manufacture and sale of tissue-engineered medical products (TEPs) and related products. The Company operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The... 
More about the company
Ratings of Japan Tissue Engineering Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about JAPAN TISSUE ENGINEERING CO., LTD.
09/20JAPAN TISSUE ENGINEERING CO., LTD.(J : 7774) dropped from S&P Global BMI Index
CI
09/14Japan Tissue Engineering Co., Ltd. Announces Approval of Autologous Cultured Oral Mucos..
CI
07/30Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
07/30Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March..
CI
06/17Japan Tissue Engineering Co., Ltd. Announces Approval Obtained for Autologous Cultured ..
CI
05/24Japan Tissue Engineering Co., Ltd. Announces Marketing Approval of Autologous Cultured ..
CI
04/28Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for Fiscal Year Ending Ma..
CI
04/28Japan Tissue Engineering Co., Ltd. Reports Non-Consolidated Earnings Results for the Ye..
CI
01/29Japan Tissue Engineering Co., Ltd. Provides Financial Guidance for Fiscal Year Ending M..
CI
01/29Japan Tissue Engineering Co., Ltd. Announces Non-Consolidated Financial Results for the..
CI
2020Japan Tissue Engineering Co., Ltd. Announces Difficulties to Reasonably Calculate the B..
CI
2020Japan Tissue Engineering Co., Ltd. Reports Consolidated Earnings Results for the Second..
CI
2020Japan Tissue Engineering Co., Ltd. Do Not Provides Earnings Guidance for the Fiscal Yea..
CI
2020Japan Tissue Engineering Co., Ltd. Announces Non-Consolidated Earnings Results for the ..
CI
2020Japan Tissue Engineering Co., Ltd. Reports Non Consolidated Earnings Results for the Ye..
CI
More news
News in other languages on JAPAN TISSUE ENGINEERING CO., LTD.

- No features available -

More news
Chart JAPAN TISSUE ENGINEERING CO., LTD.
Duration : Period :
Japan Tissue Engineering Co., Ltd. Technical Analysis Chart | 7774 | JP3389610001 | MarketScreener
Technical analysis trends JAPAN TISSUE ENGINEERING CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 667,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ken-ichiro Hata Executive President & Representative Director
Yukio Mori Executive Officer & Manager-Production Technology
Masukazu Iie Executive Officer, Manager-Research & Development
Masahito Obayashi Head-Personnel, Accounting & Compliance
Toshihiro Osuka Director & Senior Managing Executive Officer
Sector and Competitors